179 related articles for article (PubMed ID: 35163112)
1. In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P
Schlicher L; Kulig P; von Münchow A; Murphy MJ; Keller MP
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163112
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of murine sclerodermatous models by the selective S1P
Kano M; Kobayashi T; Date M; Tennichi M; Hamaguchi Y; Strasser DS; Takehara K; Matsushita T
Sci Rep; 2019 Jan; 9(1):658. PubMed ID: 30679645
[TBL] [Abstract][Full Text] [Related]
3. Cenerimod, a novel selective S1P
Piali L; Birker-Robaczewska M; Lescop C; Froidevaux S; Schmitz N; Morrison K; Kohl C; Rey M; Studer R; Vezzali E; Hess P; Clozel M; Steiner B; Bolli MH; Nayler O
Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226621
[TBL] [Abstract][Full Text] [Related]
4. Preclinical to clinical translation of cenerimod, a novel S1P
Strasser DS; Froidevaux S; Sippel V; Gerossier E; Grieder U; Pierlot GM; Kieninger-Graefitsch A; Vezzali E; Stalder AK; Renault B; Ryge J; Hart A; Mentzel U; Groenen PMA; Keller MP; Trendelenburg M; Martinic MM; Murphy MJ
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917831
[TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution, metabolism, and excretion of cenerimod, a selective S1P
Boof ML; van Lier JJ; English S; Fischer H; Ufer M; Dingemanse J
Xenobiotica; 2020 Aug; 50(8):947-956. PubMed ID: 32105166
[TBL] [Abstract][Full Text] [Related]
6. [Effects of sphingosine 1-phosphate on functions of T cell - review].
Huang WR; Wang LS; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068
[TBL] [Abstract][Full Text] [Related]
7. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches.
Halin C; Scimone ML; Bonasio R; Gauguet JM; Mempel TR; Quackenbush E; Proia RL; Mandala S; von Andrian UH
Blood; 2005 Aug; 106(4):1314-22. PubMed ID: 15870184
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation.
Messias CV; Santana-Van-Vliet E; Lemos JP; Moreira OC; Cotta-de-Almeida V; Savino W; Mendes-da-Cruz DA
PLoS One; 2016; 11(1):e0148137. PubMed ID: 26824863
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and Pharmacodynamics of Cenerimod, A Selective S1P
Juif PE; Dingemanse J; Winkle P; Ufer M
Clin Transl Sci; 2021 Jan; 14(1):143-147. PubMed ID: 32860737
[TBL] [Abstract][Full Text] [Related]
10. Type 1 sphingosine 1-phosphate G protein-coupled receptor signaling of lymphocyte functions requires sulfation of its extracellular amino-terminal tyrosines.
Fieger CB; Huang MC; Van Brocklyn JR; Goetzl EJ
FASEB J; 2005 Nov; 19(13):1926-8. PubMed ID: 16148028
[TBL] [Abstract][Full Text] [Related]
11. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Brinkmann V
Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
[TBL] [Abstract][Full Text] [Related]
12. ST-2191, an Anellated Bismorpholino Derivative of Oxy-Fingolimod, Shows Selective S1P
Stepanovska Tanturovska B; Zivkovic A; Imeri F; Homann T; Kleuser B; Stark H; Huwiler A
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500564
[TBL] [Abstract][Full Text] [Related]
13. Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5.
Selkirk JV; Dines KC; Yan YG; Ching N; Dalvie D; Biswas S; Bortolato A; Schkeryantz JM; Lopez C; Ruiz I; Hargreaves R
J Pharmacol Exp Ther; 2021 Dec; 379(3):386-399. PubMed ID: 34535564
[TBL] [Abstract][Full Text] [Related]
14. A role for S1P and S1P1 in immature-B cell egress from mouse bone marrow.
Pereira JP; Xu Y; Cyster JG
PLoS One; 2010 Feb; 5(2):e9277. PubMed ID: 20174580
[TBL] [Abstract][Full Text] [Related]
15. Endothelial S1P
Nitzsche A; Poittevin M; Benarab A; Bonnin P; Faraco G; Uchida H; Favre J; Garcia-Bonilla L; Garcia MCL; Léger PL; Thérond P; Mathivet T; Autret G; Baudrie V; Couty L; Kono M; Chevallier A; Niazi H; Tharaux PL; Chun J; Schwab SR; Eichmann A; Tavitian B; Proia RL; Charriaut-Marlangue C; Sanchez T; Kubis N; Henrion D; Iadecola C; Hla T; Camerer E
Circ Res; 2021 Feb; 128(3):363-382. PubMed ID: 33301355
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
[TBL] [Abstract][Full Text] [Related]
17. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling.
Gatfield J; Monnier L; Studer R; Bolli MH; Steiner B; Nayler O
Cell Signal; 2014 Jul; 26(7):1576-88. PubMed ID: 24704119
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
